Cellarity’s platform digitizes the molecular information in cells to elucidate how they behave in health and disease. Founded by Nick Plugis in 2017, Cellarity is backed by investors that include BlackRock, Flagship Pioneering, The Baupost Group, and Pictet Private Equity Investors S.A. and is headquartered in Cambridge.